Literature DB >> 19530720

Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins.

Cristian Samorì1, Andrea Guerrini, Greta Varchi, Gabriele Fontana, Ezio Bombardelli, Stella Tinelli, Giovanni Luca Beretta, Serena Basili, Stefano Moro, Franco Zunino, Arturo Battaglia.   

Abstract

The synthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins are reported. A general synthetic protocol, based on "C-5 camptothecin (C-5-CPT) enolate chemistry", allows one to obtain various C5-substituted analogues. All new compounds, obtained as 1:1 epimeric mixtures, were tested for their antiproliferative activity. Experimental data showed that all novel derivatives are less active than the reference compounds and that one of the two epimers is more active than the other. Molecular docking simulations were performed to achieve more insight into the interactions between the new C5-modified CPTs and Topo I. A good correlation was observed when the data of cytotoxicity and the values calculated for the free binding energy were combined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530720     DOI: 10.1021/jm801153y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.

Authors:  Sai Fang; Lei Chen; Miao Yu; Bao Cheng; Yongsheng Lin; Susan L Morris-Natschke; Kuo-Hsiung Lee; Qiong Gu; Jun Xu
Journal:  Org Biomol Chem       Date:  2015-04-28       Impact factor: 3.876

Review 2.  Perspectives on biologically active camptothecin derivatives.

Authors:  Ying-Qian Liu; Wen-Qun Li; Susan L Morris-Natschke; Keduo Qian; Liu Yang; Gao-Xiang Zhu; Xiao-Bing Wu; An-Liang Chen; Shao-Yong Zhang; Xiang Nan; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-03-21       Impact factor: 12.944

3.  Development of an enzyme‑linked immunosorbent assay for camptothecin.

Authors:  Liting Yan; Xiang Nan; Cunzheng Zhang; Haifang Wang; Xiaoyan Huang; Jun Hu; Yingqian Liu
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.